The Cooper Companies, Inc. (FRA:CP60)

Market Cap	10.39B -18.5%
Revenue (ttm)	3.68B +4.7%
Net Income	495.76M +39.8%
EPS	2.59 +42.4%
Shares Out	n/a
PE Ratio	21.07
Forward PE	13.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	54.62
Previous Close	51.54
Day's Range	54.62 - 54.62
52-Week Range	46.01 - 74.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 3, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CP60

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 25, 2026

Data Sources Report a data error